<ul data-eligibleForWebStory="false"><li>Dutch-based Plasmacure, developer of the PLASOMA cold plasma system for complex wound treatment, secures €6M funding in Series A investment led by U.S.-based Venture Medical.</li><li>Venture Medical to lead U.S. go-to-market financing exceeding $10M for Plasmacure's regulatory approval and reimbursement in the United States.</li><li>Investment consortium includes Dutch health insurer Coöperatie VGZ, impact investor Noaber, Stichting Triade, EIC Fund, and Oost NL.</li><li>Funding to support global expansion of PLASOMA to treat complex wounds, providing a more effective solution than standard treatments with up to 2.5 times greater effectiveness.</li></ul>

Dutch-based Plasmacure raises €6M to help treat complex wounds; also secures €8.5M+ US go-to-market financing

Discover more